HEALTHSTORY 707· JUNE 26, 2026

BIO 2026 in San Diego Signals a Mood Shift for the Biotech Industry

BIO 2026, one of the largest annual gatherings of biotechnology companies and investors, brought delegations from dozens of countries to San Diego and delivered something the industry had not felt at several comparable events in the prior…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 706Decoy Therapeutics Raises Up to $21 Million in Private Placement to Fund Novel Antiviral Platform NEXT STORY 708 →U.S. Strikes Iran as Trump Cites Ceasefire Violation in Strait of Hormuz

Keep reading

More from the desk.

13HEALTH

FDA clears first CELMoD drug for blood cancer as a $6.7 billion shareholder lawsuit returns to court

Multiple myeloma, a blood cancer, now has a new oral treatment approved by U.S. regulators. The Food and Drug Administration cleared Zenbexus, made by Bristol Myers Squibb, as the first drug in a new class called CELMoDs and the first drug…

health2 MIN

51HEALTH

Autoimmune research pioneer Georg Schett co-founds his first biotech, choosing antibody therapies over CAR-T

Georg Schett, the German scientist who spent five years demonstrating that CAR-T therapy, a treatment that engineers a patient's own immune cells to target and eliminate the source of disease, can reset the immune system in autoimmune…

health2 MIN

67HEALTH

Splitting the MMR vaccine risks more missed doses and more sick children, history suggests

Separating the MMR vaccine into individual shots is likely to produce more missed doses and more sick kids. The MMR is a single injection covering measles, mumps, and rubella. It is now the target of a White House executive order

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk